Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001437749-24-031358
Filing Date
2024-10-16
Accepted
2024-10-16 16:19:35
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM DEFM14A nby20241012_defm14a.htm DEFM14A 1654236
2 a01.jpg GRAPHIC 161692
3 a02.jpg GRAPHIC 150741
4 b01.jpg GRAPHIC 13966
5 b02.jpg GRAPHIC 11083
6 b03.jpg GRAPHIC 10098
7 logo.jpg GRAPHIC 3886
8 sig01.jpg GRAPHIC 8438
  Complete submission text file 0001437749-24-031358.txt   2151331
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-33678 | Film No.: 241374846
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)